NCT02345213View on ClinicalTrials.gov

A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

March 1, 2015

Primary Completion Date

May 15, 2017

Study Completion Date

March 26, 2018

Conditions
Dementia, Lewy BodyLewy Body Disease
Interventions
DRUG

E2020

E2020 tablets will be orally administered once daily after breakfast

DRUG

Placebo

Matching placebo tablets will be orally administered once daily after breakfast

Trial Locations (1)

Unknown

Saitama

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT02345213 - A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB) | Biotech Hunter | Biotech Hunter